Arylacetamide Deacetylase (Esterase) (AADAC) Peptide
AADAC
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all AADAC products
- AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-AADAC antibody (Catalog #: ARP45036_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
- Synonyms
- MGC89272 Peptide, AADAC Peptide, CES5A1 Peptide, DAC Peptide, Aada Peptide, 5033417E09Rik Peptide, AI265437 Peptide, arylacetamide deacetylase Peptide, arylacetamide deacetylase S homeolog Peptide, Arylacetamide deacetylase Peptide, arylacetamide deacetylase (esterase) Peptide, LOC100056411 Peptide, aadac Peptide, AADAC Peptide, aadac.S Peptide, LOC100451808 Peptide, ACD3 Peptide, PTRG_10278 Peptide, aaad Peptide, Aadac Peptide
- Background
-
Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-5 AV705031.1 1-5 6-247 L32179.1 1-242 248-1725 BC032309.1 183-1660
Alias Symbols: CES5A1, DAC
Protein Size: 399 - Molecular Weight
- 46 kDa
- Gene ID
- 13
- NCBI Accession
- NM_001086, NP_001077
- UniProt
- P22760
-
You are here:
